Saturday 17 October 2026
Export HITI’s income statement to Excel — free account
High Tide Inc.
HITI Healthcare Pharmaceutical Retailers
High Tide Inc.’s revenue for fiscal 2025 (year ended October 2025) was $424.0 million, up 10.5% from fiscal 2024. In the quarter to July 2026, revenue grew 30.7%, EPS grew 800.0%, free cash flow fell 7.91% and total debt rose 54.7%, each against the same quarter a year earlier. Revenue growth for five consecutive years.
2.57
0.01
+0.39%
Follow HITI
| Jul '26 | Apr '26 | Jan '26 | Oct '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
4 | 3 | 2 | 2 |
+8 more TTM periods Free account |
| (25.05%) | (36.16%) | (38.02%) | (40.19%) | ||
| (10.50%) | (15.11%) | (16.07%) | (16.85%) | ||
ROIC |
(0.64%) | (2.55%) | (4.78%) | (5.89%) | |
Return on Tangible Assets |
(42.50%) | (61.24%) | (66.50%) | (76.42%) | |
Average Days of Receivables |
5.13 | 4.23 | 5.05 | 3.45 | |
Free Cash Flow per Share |
0.13 | 0.13 | 0.16 | 0.12 | |
Free Cash Flow |
11.14 | 11.64 | 13.67 | 9.69 | |
Capital Expenditures |
(6.24) | (6.61) | (7.12) | (7.35) | |
| Other line items | |||||
Cash ROIC |
5.59% | 6.75% | 7.59% | 5.45% | |
Accounts Receivable Turnover |
105.10 | 128.54 | 104.13 | 131.71 | |
Accounts Payable Turnover |
14.35 | 12.85 | 13.19 | 12.28 | |
Inventory Turnover |
10.81 | 9.96 | 9.67 | 9.03 | |
Average Days of Payables |
35.78 | 41.00 | 38.62 | 39.16 | |
Days of Inventory on Hand |
45.91 | 53.12 | 52.26 | 55.86 | |
Tax Rate |
0.00 | 0.01 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
16.62% | 16.94% | 17.29% | 17.73% | |
Share Based Compensation of Revenue |
0.38% | 0.41% | 0.49% | 0.66% | |
Interest Coverage |
(0.09) | (0.37) | (0.74) | (1.12) | |
Operating CF/Net income |
(0.73) | (0.58) | (0.62) | (0.47) | |
Depreciation/Fixed assets |
0.89 | 0.91 | 0.91 | 0.83 | |
Capex/Depreciation |
(0.33) | (0.34) | (0.38) | (0.42) | |
Revenue per Share |
5.91 | 5.53 | 5.16 | 5.16 | |
Operating CF per Share |
0.20 | 0.21 | 0.24 | 0.21 | |
Capex per Share |
(0.07) | (0.08) | (0.08) | (0.09) | |
Capex to Sales |
0.01 | 0.01 | 0.02 | 0.02 |
Columns are period end dates · fundamentals updated 2 Oct 2026